StockNews.com assumed coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a report issued on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. OncoSec Medical Stock Down 7.1 % Shares of ONCS opened at $0.20 on Friday. OncoSec Medical has a 12-month low of $0.18 and a 12-month high […]